According to Orchard Therapeutics 's latest financial reports the company's current EPS (TTM) is -6,06ย โฌ. In 2020 the company made an earnings per share (EPS) of -13,08ย โฌ an increase over its 2019 EPS that were of -14,94ย โฌ.